Advances in Mycobacterium siderophore-based drug discovery

Tuberculosis remains a public health threat of global proportions. Iron is a scarce resource indispensable to both host and pathogen during infection with Mycobacterium tuberculosis, the causative agent of tuberculosis. Siderophores are critical molecules for iron acquisition under iron-limiting con...

Full description

Bibliographic Details
Main Authors: Jun-li He, Jian-ping Xie
Format: Article
Language:English
Published: Elsevier 2011-06-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383511000098
id doaj-dfc77fb611e14474b4816bbd13ec2760
record_format Article
spelling doaj-dfc77fb611e14474b4816bbd13ec27602020-11-25T01:10:33ZengElsevierActa Pharmaceutica Sinica B2211-38352211-38432011-06-011181310.1016/j.apsb.2011.04.008Advances in Mycobacterium siderophore-based drug discoveryJun-li HeJian-ping XieTuberculosis remains a public health threat of global proportions. Iron is a scarce resource indispensable to both host and pathogen during infection with Mycobacterium tuberculosis, the causative agent of tuberculosis. Siderophores are critical molecules for iron acquisition under iron-limiting conditions and, as a very efficient pathogen, M. tuberculosis has evolved elaborate siderophores knowledge of which is being intensively translated into clinical practice. This paper summarizes the structures, types and physiological functions of Mycobacterium siderophores with emphasis on siderophore-inspired design of drugs and drug delivery vehicles.http://www.sciencedirect.com/science/article/pii/S2211383511000098TuberculosisMycobacterium tuberculosisSiderophoreDrug vectorDrug design
collection DOAJ
language English
format Article
sources DOAJ
author Jun-li He
Jian-ping Xie
spellingShingle Jun-li He
Jian-ping Xie
Advances in Mycobacterium siderophore-based drug discovery
Acta Pharmaceutica Sinica B
Tuberculosis
Mycobacterium tuberculosis
Siderophore
Drug vector
Drug design
author_facet Jun-li He
Jian-ping Xie
author_sort Jun-li He
title Advances in Mycobacterium siderophore-based drug discovery
title_short Advances in Mycobacterium siderophore-based drug discovery
title_full Advances in Mycobacterium siderophore-based drug discovery
title_fullStr Advances in Mycobacterium siderophore-based drug discovery
title_full_unstemmed Advances in Mycobacterium siderophore-based drug discovery
title_sort advances in mycobacterium siderophore-based drug discovery
publisher Elsevier
series Acta Pharmaceutica Sinica B
issn 2211-3835
2211-3843
publishDate 2011-06-01
description Tuberculosis remains a public health threat of global proportions. Iron is a scarce resource indispensable to both host and pathogen during infection with Mycobacterium tuberculosis, the causative agent of tuberculosis. Siderophores are critical molecules for iron acquisition under iron-limiting conditions and, as a very efficient pathogen, M. tuberculosis has evolved elaborate siderophores knowledge of which is being intensively translated into clinical practice. This paper summarizes the structures, types and physiological functions of Mycobacterium siderophores with emphasis on siderophore-inspired design of drugs and drug delivery vehicles.
topic Tuberculosis
Mycobacterium tuberculosis
Siderophore
Drug vector
Drug design
url http://www.sciencedirect.com/science/article/pii/S2211383511000098
work_keys_str_mv AT junlihe advancesinmycobacteriumsiderophorebaseddrugdiscovery
AT jianpingxie advancesinmycobacteriumsiderophorebaseddrugdiscovery
_version_ 1725174081658028032